Critical

Macrophage activation syndrome

Cytokine storm in rheumatic disease · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A form of secondary haemophagocytic lymphohistiocytosis triggered by rheumatic disease (especially systemic JIA and adult-onset Still's) or infection, causing uncontrolled macrophage/T-cell activation. It presents with persistent high fever, cytopenias, hyperferritinaemia, hepatic dysfunction and rapidly evolving multi-organ failure.

Red flags

  • Ferritin rising rapidly into tens of thousands
  • Falling fibrinogen with rising triglycerides and transaminases
  • New cytopenias in a previously flaring patient
  • Encephalopathy, seizures or coma
  • Haemorrhage with DIC and multi-organ failure

Assessment

Differential diagnosis

  • Sepsis / septic shock
  • Disease flare (Still's, SLE)
  • Disseminated intravascular coagulation
  • Acute leukaemia / lymphoma
  • Viral infection (EBV, CMV) driving HLH
  • Drug reaction (DRESS)

Investigations

  • Ferritin (often >10,000 micrograms/L; rapid rise is highly suggestive)
  • FBC (falling cell lines - bi/pancytopenia), fibrinogen (falling), triglycerides (rising)
  • LFTs, LDH, coagulation screen, D-dimer
  • Soluble CD25 (IL-2 receptor) and natural-killer cell activity
  • Bone marrow aspirate showing haemophagocytosis (not always present)
  • Septic screen and viral PCRs (EBV, CMV)

Management

  • Recognise the paradox: falling ESR with rising ferritin and falling fibrinogen in a febrile Still's/SLE patient suggests MAS
  • Resuscitate (ABC), take to a monitored/HDU-ICU setting and involve rheumatology and haematology urgently
  • Send full MAS panel including ferritin, fibrinogen, triglycerides, soluble CD25
  • Treat any infective trigger with broad-spectrum antimicrobials and antivirals as indicated
  • Start high-dose corticosteroid as first-line immunosuppression
  • Add anakinra (IL-1 blockade) early for refractory or rapidly deteriorating disease
  • Escalate to ciclosporin, IVIG or etoposide-based protocols with specialist (HLH) input if no response
  • Supportive care: transfuse for bleeding, correct coagulopathy, treat organ failure

Drugs & doses

Methylprednisolone — 1 g IV OD for 3 days, then high-dose taper
Anakinra — 2-4 mg/kg/day IV/SC (titrate upward in refractory MAS)
Ciclosporin — 2-4 mg/kg/day IV/PO adjusted to levels
IVIG — 1-2 g/kg total over 2 days
Dexamethasone — 10 mg/m2/day (HLH-2004 protocol) with etoposide in refractory cases

Disposition

Admit to HDU/ICU under combined rheumatology-haematology care; immediate immunosuppression and supportive organ support.

Complications & pitfalls

  • Multi-organ failure and death
  • Disseminated intravascular coagulation
  • Acute liver failure
  • CNS involvement (seizures, coma)
  • Secondary infection from immunosuppression

Exam pearls

  • HScore and MAS classification criteria aid diagnosis but do not delay treatment
  • A normal or low ESR with very high ferritin is a classic clue (fibrinogen consumption)
  • Infection and MAS coexist - treat both
  • Soluble CD25 and CD163 are sensitive markers if available

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.